Capstan Medical

Capstan Medical is a medical technology startup focused on developing robotic-enabled minimally invasive solutions for treating heart valve disease. Founded in 2020 by Dan Wallace and David Schummers, the company has a team of over 75 employees with expertise in heart valve technology, implant delivery, and robotics. Capstan Medical is backed by Intuitive Ventures and has its offices in Santa Cruz, California, and Auckland, New Zealand. The company's core offering includes a nitinol-enabled mitral valve implant designed for minimally invasive deployment, a novel delivery catheter for precise valve placement, and a custom-built robotic platform that enhances surgical control. Capstan Medical has recently conducted first-in-human cases using its mitral valve implant system and is also developing a system for tricuspid valve replacement. Their innovative approach aims to expand treatment options for patients with heart valve disease through advanced surgical robotics and transcatheter heart valve replacement techniques.